All Stories

  1. Long term results of single high dose Stereotactic Body Radiotherapy in the treatment of primary lung tumors

    Article • Scientific Reports, October 2019, Springer Science + Business Media

    Prof MATTIA F OSTI

  2. Comparative effectiveness of multi-fraction stereotactic radiosurgery for surgically resected or intact large brain metastases from non-small-cell lung cancer (NSCLC)

    Article • Lung Cancer, June 2019, Elsevier

    Prof MATTIA F OSTI

  3. 30 Gy single dose stereotactic body radiation therapy (SBRT): Report on outcome in a large series of patients with lung oligometastatic disease

    Article • Lung Cancer, August 2018, Elsevier

    Prof MATTIA F OSTI

  4. Preoperative intensity-modulated radiotherapy with a simultaneous integrated boost combined with Capecitabine in locally advanced rectal cancer: short-term results of a multicentric study

    Article • Radiation Oncology, August 2017, Springer Science + Business Media

    Prof MATTIA F OSTI

  5. Radiation therapy for older patients with brain tumors

    Article • Radiation Oncology, June 2017, Springer Science + Business Media

    Prof MATTIA F OSTI

  6. Critical decision-making in radiotherapy for early stage breast cancer in a neo-adjuvant treatment era

    Article • Expert Review of Anticancer Therapy, March 2017, Taylor & Francis

    Prof MATTIA F OSTI

  7. Outcomes of postoperative stereotactic radiosurgery to the resection cavity versus stereotactic radiosurgery alone for melanoma brain metastases

    Article • Journal of Neuro-Oncology, March 2017, Springer Science + Business Media

    Prof MATTIA F OSTI

  8. Lung Metastases Treated With Stereotactic Ablative Radiation Therapy in Oligometastatic Colorectal Cancer Patients: Outcomes and Prognostic Factors After Long-Term Follow-Up

    Article • Clinical Colorectal Cancer, March 2017, Elsevier

    Prof MATTIA F OSTI

  9. Mono- and Bi-weekly Hypofractionated Radiation Therapy for the Treatment of Epithelial Skin Cancer in Very Elderly Patients

    Article • Anticancer Research, February 2017, International Institute of Anticancer Research

    Prof MATTIA F OSTI

  10. Second cancer incidence in primary mediastinal B-cell lymphoma treated with methotrexate with leucovorin rescue, doxorubicin, cyclophosphamide, vincristine, prednisone, and bleomycin regimen with or without rituximab and mediastinal radiotherapy: Results

    Article • Hematological Oncology, January 2017, Wiley

    Professor Marco Alfo', Professor Vincenzo Tombolini, Prof MATTIA F OSTI

  11. Target delineation and optimal radiosurgical dose for pituitary tumors

    Article • Radiation Oncology, October 2016, Springer Science + Business Media

    Prof MATTIA F OSTI

  12. Single-Fraction Versus Multifraction (3 × 9 Gy) Stereotactic Radiosurgery for Large (>2 cm) Brain Metastases: A Comparative Analysis of Local Control and Risk of Radiation-Induced Brain Necrosis

    Article • International Journal of Radiation Oncology*Biology*Physics, July 2016, Elsevier

    Prof MATTIA F OSTI

  13. Value of diffusion-weighted MRI and apparent diffusion coefficient measurements for predicting the response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy

    Article • Abdominal Radiology, June 2016, Springer Science + Business Media

    Prof MATTIA F OSTI

  14. Different outcomes among favourable and unfavourable intermediate-risk prostate cancer patients treated with hypofractionated radiotherapy and androgen deprivation therapy

    Article • Radiation Oncology, June 2016, Springer Science + Business Media

    Prof MATTIA F OSTI

  15. Renin-Angiotensin System Inhibitors Might Help to Reduce the Development of Symptomatic Radiation Pneumonitis After Stereotactic Body Radiotherapy for Lung Cancer

    Article • Clinical Lung Cancer, May 2016, Elsevier

    Prof MATTIA F OSTI

  16. Adjuvant radiochemotherapy for gastric cancer: Should we use prognostic factors to select patients?

    Article • World Journal of Gastroenterology, January 2016, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Prof MATTIA F OSTI

  17. Repeated stereotactic radiosurgery for patients with progressive brain metastases

    Article • Journal of Neuro-Oncology, September 2015, Springer Science + Business Media

    Prof MATTIA F OSTI

  18. Potential Role of Single Nucleotide Polymorphisms of XRCC1, XRCC3, and RAD51 in Predicting Acute Toxicity in Rectal Cancer Patients Treated With Preoperative Radiochemotherapy

    Article • American Journal of Clinical Oncology, March 2015, Wolters Kluwer Health

    Prof MATTIA F OSTI

  19. Hypofractionated stereotactic radiotherapy in combination with bevacizumab or fotemustine for patients with progressive malignant gliomas

    Article • Journal of Neuro-Oncology, February 2015, Springer Science + Business Media

    Prof MATTIA F OSTI

  20. Manipulation of radiation-induced bystander effect in prostate adenocarcinoma by dose and tumor differentiation grade: In vitro study

    Article • International Journal of Radiation Biology, January 2015, Taylor & Francis

    Prof MATTIA F OSTI

  21. Adjuvant chemoradiotherapy in gastric cancer: a pooled analysis of the AIRO Gastrointestinal Group experience

    Article • Tumori Journal, January 2015, Wichtig

    Prof. Dr. Gianaurelio CUNIBERTI, Prof MATTIA F OSTI

  22. No benefit of adjuvant Fluorouracil Leucovorin chemotherapy after neoadjuvant chemoradiotherapy in locally advanced cancer of the rectum (LARC): Long term results of a randomized trial (I-CNR-RT)

    Article • Radiotherapy and Oncology, November 2014, Elsevier

    Prof. Dr. Gianaurelio CUNIBERTI, Prof MATTIA F OSTI

  23. Image guided intensity modulated hypofractionated radiotherapy in high-risk prostate cancer patients treated four or five times per week: analysis of toxicity and preliminary results

    Article • Radiation Oncology, September 2014, Springer Science + Business Media

    Prof MATTIA F OSTI

  24. Neoadjuvant chemoradiation with concomitant boost radiotherapy associated to capecitabine in rectal cancer patients

    Article • International Journal of Colorectal Disease, May 2014, Springer Science + Business Media

    Prof MATTIA F OSTI

  25. Fractionated stereotactic radiosurgery for patients with skull base metastases from systemic cancer involving the anterior visual pathway

    Article • Radiation Oncology, May 2014, Springer Science + Business Media

    Prof MATTIA F OSTI

  26. Whole brain reirradiation and concurrent temozolomide in patients with brain metastases

    Article • Journal of Neuro-Oncology, April 2014, Springer Science + Business Media

    Prof MATTIA F OSTI

  27. Fractionated stereotactic radiosurgery for patients with brain metastases

    Article • Journal of Neuro-Oncology, February 2014, Springer Science + Business Media

    Prof MATTIA F OSTI

  28. Image-Guided Hypofractionated Radiotherapy in Low-Risk Prostate Cancer Patients

    Article • BioMed Research International, January 2014, Hindawi Publishing Corporation

    Prof MATTIA F OSTI

  29. Cytokines, Fatigue, and Cutaneous Erythema in Early Stage Breast Cancer Patients Receiving Adjuvant Radiation Therapy

    Article • BioMed Research International, January 2014, Hindawi Publishing Corporation

    Prof MATTIA F OSTI

  30. Clinical Outcomes of Single Dose Stereotactic Radiotherapy for Lung Metastases

    Article • Clinical Lung Cancer, November 2013, Elsevier

    Prof MATTIA F OSTI

  31. Chemoradiation for anaplastic oligodendrogliomas: clinical outcomes and prognostic value of molecular markers

    Article • Journal of Neuro-Oncology, October 2013, Springer Science + Business Media

    Prof MATTIA F OSTI

  32. Clinical and technical characteristics of intraoperative radiotherapy

    Article • Strahlentherapie und Onkologie, July 2013, Springer Science + Business Media

    Prof. Dr. Gianaurelio CUNIBERTI, Prof MATTIA F OSTI

  33. The importance of lymph node retrieval and lymph node ratio following preoperative chemoradiation of rectal cancer

    Article • Colorectal Disease, July 2013, Wiley

    Prof MATTIA F OSTI

  34. Radiation therapy after breast reconstruction: outcomes, complications, and patient satisfaction

    Article • La radiologia medica, June 2013, Springer Science + Business Media

    Prof MATTIA F OSTI

  35. Image Guided Hypofractionated 3-Dimensional Radiation Therapy in Patients With Inoperable Advanced Stage Non-Small Cell Lung Cancer

    Article • International Journal of Radiation Oncology*Biology*Physics, March 2013, Elsevier

    Prof MATTIA F OSTI

  36. Intermediate-risk prostate cancer patients treated with androgen deprivation therapy and a hypofractionated radiation regimen with or without image guided radiotherapy

    Article • Radiation Oncology, January 2013, Springer Science + Business Media

    Prof MATTIA F OSTI

  37. Stereotactic radiosurgery in elderly patients with brain metastases

    Article • Journal of Neuro-Oncology, November 2012, Springer Science + Business Media

    Prof MATTIA F OSTI

  38. Curative radiotherapy in patients with anal cancer: clinical outcomes and prognostic factors in a single-institution experience

    Article • La radiologia medica, November 2012, Springer Science + Business Media

    Prof MATTIA F OSTI

  39. Integral Dose and Radiation-Induced Secondary Malignancies: Comparison between Stereotactic Body Radiation Therapy and Three-Dimensional Conformal Radiotherapy

    Article • International Journal of Environmental Research and Public Health, November 2012, MDPI AG

    Prof MATTIA F OSTI

  40. Impact of Different Treatment Approaches on Pregnancy Outcomes in 99 Women Treated for Hodgkin Lymphoma

    Article • International Journal of Radiation Oncology*Biology*Physics, November 2012, Elsevier

    Prof MATTIA F OSTI

  41. External-beam radiotherapy and/or HDR brachytherapy in postoperative endometrial cancer patients: clinical outcomes and toxicity rates

    Article • La radiologia medica, May 2012, Springer Science + Business Media

    Prof MATTIA F OSTI

  42. Intensity modulated radiotherapy in early stage Hodgkin lymphoma patients: Is it better than three dimensional conformal radiotherapy?

    Article • Radiation Oncology, January 2012, Springer Science + Business Media

    Prof MATTIA F OSTI

  43. Frameless linac-based stereotactic radiosurgery (SRS) for brain metastases: analysis of patient repositioning using a mask fixation system and clinical outcomes

    Article • Radiation Oncology, November 2011, Springer Science + Business Media

    Prof MATTIA F OSTI

  44. Acute toxicity in 14 patients with locally advanced head and neck squamous cell carcinoma treated with concurrent cetuximab and radiotherapy

    Article • La radiologia medica, September 2011, Springer Science + Business Media

    Prof MATTIA F OSTI

  45. Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis

    Article • Radiation Oncology, May 2011, Springer Science + Business Media

    Prof MATTIA F OSTI

  46. Fractionated stereotactic conformal radiotherapy for large benign skull base meningiomas

    Article • Radiation Oncology, April 2011, Springer Science + Business Media

    Prof MATTIA F OSTI

  47. Fractionated stereotactic reirradiation and concurrent temozolomide in patients with recurrent glioblastoma

    Article • Journal of Neuro-Oncology, November 2010, Springer Science + Business Media

    Prof MATTIA F OSTI

  48. Primary cutaneous Hodgkin lymphoma

    Article • Journal of the American Academy of Dermatology, August 2010, Elsevier

    Prof MATTIA F OSTI

  49. Late morbidity and oncological outcome after radical hypofractionated radiotherapy in men with prostate cancer

    Article • BJU International, May 2010, Wiley

    Prof MATTIA F OSTI

  50. Long-term results of 60 patients with pathologic stage I & IIA Hodgkin's disease treated with exclusive mantle radiation therapy

    Article • European Journal Of Haematology, April 2009, Wiley

    Prof MATTIA F OSTI

  51. The Radiotherapist’s Point of View

    Article • January 2009, Springer Science + Business Media

    Prof MATTIA F OSTI

  52. MACOP-B and Involved-Field Radiotherapy Is an Effective and Safe Therapy for Primary Mediastinal Large B Cell Lymphoma

    Article • International Journal of Radiation Oncology*Biology*Physics, November 2008, Elsevier

    Prof MATTIA F OSTI

  53. Hypofractionated radiotherapy followed by adjuvant chemotherapy with temozolomide in elderly patients with glioblastoma

    Article • Journal of Neuro-Oncology, August 2008, Springer Science + Business Media

    Prof MATTIA F OSTI

  54. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients

    Article • Journal of Neuro-Oncology, February 2008, Springer Science + Business Media

    Prof MATTIA F OSTI

  55. Retroperitoneal mesenchymal chondrosarcoma mimicking a large retroperitoneal sacral schwannoma

    Article • Neurosurgical Review, October 2007, Springer Science + Business Media

    Prof MATTIA F OSTI

  56. Radiotherapy for nonfunctioning pituitary adenomas: from conventional to modern stereotactic radiation techniques

    Article • Neurosurgical Review, May 2007, Springer Science + Business Media

    Prof MATTIA F OSTI

  57. Long-term follow-up results of postoperative radiation therapy for Cushing’s disease

    Article • Journal of Neuro-Oncology, March 2007, Springer Science + Business Media

    Prof MATTIA F OSTI

  58. Radiotherapy and sequential temozolomide compared with radiotherapy with concomitant and sequential temozolomide in the treatment of newly diagnosed glioblastoma multiforme

    Article • Anti-Cancer Drugs, September 2006, Wolters Kluwer Health

    Prof MATTIA F OSTI

  59. The long-term efficacy of conventional radiotherapy in patients with GH-secreting pituitary adenomas

    Article • Clinical Endocrinology, February 2005, Wiley

    Prof MATTIA F OSTI

  60. Detection of Colon Cancer with99mTc-Labeled Bombesin Derivative (99mTc-leu13-BN1)

    Article • Cancer Biotherapy & Radiopharmaceuticals, April 2004, Mary Ann Liebert Inc

    Prof MATTIA F OSTI

  61. Long-term outcome after multimodality treatment for stage III thymic tumors

    Article • The Annals of Thoracic Surgery, December 2003, Elsevier

    Prof MATTIA F OSTI

  62. Hodgkin's disease of the nasopharynx: diagnostic and therapeutic approach with a review of the literature

    Article • Annals of Hematology, September 2002, Springer Science + Business Media

    Prof MATTIA F OSTI

  63. Article • Journal of Neuro-Oncology, January 2002, Springer Science + Business Media

    Prof MATTIA F OSTI

  64. Radiological assessment of necrosis in glioblastoma: variability and prognostic value

    Article • Neuroradiology, March 1998, Springer Science + Business Media

    Prof MATTIA F OSTI

  65. Acute nonlymphocytic leukemia: onset after treatment for Hodgkin's disease

    Article • Annals of Hematology, March 1997, Springer Science + Business Media

    Prof MATTIA F OSTI

  66. Three-Dimensional Computed Tomographic Imaging in the Diagnosis of Vertebral Column Trauma

    Article • February 1997, Wolters Kluwer Health

    Prof MATTIA F OSTI

  67. Supratentorial glioblastoma: neuroradiological findings and survival after surgery and radiotherapy

    Article • Neuroradiology, May 1996, Springer Science + Business Media

    Prof MATTIA F OSTI

  68. PALLIATIVE RADIOTHERAPY FOR BRAIN METASTASES

    Article • Oncology Reports, May 1995, Spandidos Publications

    Prof MATTIA F OSTI

  69. The Role of Restaging Laparotomy in Hodgkin'S Disease

    Article • Acta Oncologica, January 1989, Taylor & Francis

    Prof MATTIA F OSTI